COmmercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers

Project Information

CODIC

Grant agreement ID: 692908

DOI 10.3030/692908

Project closed

EC signature date 22 December 2015

Start date 1 January 2016

End date 30 June 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 150 000,00

EU contribution € 150 000,00

Coordinated by

KAROLINSKA INSTITUTET
Sweden

Publications

Peer reviewed articles (1)

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1

Author(s): Sabin Llona-Minguez, Andreas Höglund, Sylvain A. Jacques, Lars Johansson, José Manuel Calderón-Montaño, Magnus Claesson, Olga Loseva, Nicholas C. K. Valerie, Thomas Lundbäck, Javier Piedrafita, Giovanni Maga, Emmanuele Crespan, Laurent Meijer, Estefanía Burgos Morón, Pawel Baranczewski, Ann-Louise Hagbjörk, Richard Svensson, Elisee Wiita, Ingrid Almlöf, Torkild Visnes, Fredrik Jeppsson, K
Published in: Journal of Medicinal Chemistry, Issue 59/3, 2016, Page(s) 1140-1148, ISSN 0022-2623
Publisher: American Chemical Society
DOI: 10.1021/acs.jmedchem.5b01741